M84.574 Pathological fracture in neoplastic disease, right foot

ICD-10-CM Code M84.574: Pathological fracture in neoplastic disease, right foot

ICD-10-CM code M84.574 identifies a pathological fracture in neoplastic disease of the right foot. The terminology record classifies this concept as a disease or syndrome under the broader ankle and foot category. Clinical literature notes that foot neoplasms can be associated with such fractures, and billing articles list the code within payer specifications. 1 2 3

Plain-language overview

This diagnosis code represents a pathological fracture in neoplastic disease of the right foot, and the terminology record classifies this specific concept as a disease or syndrome. 1

What this code represents

The official preferred name for M84.574 is pathological fracture in neoplastic disease, right foot, and the terminology record indicates this concept currently has no narrower child concepts within the coding system. 1

Coding details

In the coding hierarchy, M84.574 is a child of the parent concept M84.57, which encompasses pathological fractures in neoplastic disease of the ankle and foot. 1

Clinical context

Clinical literature indicates that foot neoplasms, such as intraosseous lipomas or enchondromas, can be associated with pathological fractures observed during diagnostic imaging evaluations. 2

Documentation considerations

The terminology record for M84.574 specifies the right foot location and the neoplastic disease context, providing the exact descriptive elements needed for code alignment. 1

Coverage and utilization context

A Medicare billing and coding article for denosumab includes the exact code description for pathological fracture in neoplastic disease, right foot, within its listed coverage specifications. 3

What the sources add

While the terminology record defines the code structure, the clinical article provides operational context by describing how imaging modalities like CT scans help evaluate the extent of pathological fractures in foot neoplasms. 1 2

The CMS billing article lists M84.574 alongside related codes for left foot fractures and sequelae, illustrating how this specific right foot diagnosis fits into a broader payer coding context. 3 4

Questions to verify

The CMS billing article lists the right foot code description immediately adjacent to descriptions for initial encounter and left foot sequela, raising questions about specific encounter extensions. 3 4

Sources

1. ICD-10-CM M84.574 terminology record — National Cancer Institute Enterprise Vocabulary Services; accessed 2026-07-27.
2. Benign bone and soft tissue tumors of the foot — pmc.ncbi.nlm.nih.gov; accessed 2026-07-27.
3. Article - Billing and Coding: Denosumab (Prolia ™, Xgeva ™) (A52399) — cms.gov; accessed 2026-07-27.
4. Article - Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®, Wyost®, Ospomyv™,Xbryk™,Bomyntra®, Conexxence®, Stoboclo®, Osenvelt®) (A52399) — cms.gov; accessed 2026-07-27.
5. Page:ICD-10-CM (2010).djvu/882 - Wikisource, the free online library — en.wikisource.org; accessed 2026-07-27.